Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in

  News Archive

Potential Treatment for Muscular Dystrophy
Wednesday, August 05, 2015
A new method for producing muscle cells could offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options.

Shire Acquires Foresight Biotherapeutics
Tuesday, August 04, 2015
With the acquisition, Shire acquires the global rights to FST-100 a therapy in late-stage development for the treatment of infectious conjunctivitis, an ocular surface condition commonly referred to as pink eye.

Crucial for Stem Cell Survival Protein Identified Using Editing Tool CRISPR
Monday, August 03, 2015
A team of University of Wisconsin-Madison engineers has identified a protein that is integral to the survival and self-renewal processes of human pluripotent stem cells (hPSC).

Malvern Instruments Establishes New Biopharmaceutical Applications Laboratory
Friday, July 31, 2015
Malvern Instruments has established a new biopharmaceutical applications laboratory in the heart of San Diego’s biotechnology cluster.

A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
Thursday, July 30, 2015
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases

Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
Wednesday, July 29, 2015
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.

BioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec Cell Therapy Vials
Wednesday, July 29, 2015
BioCision and Cook ink exclusive deal to combine technologies to standardize cell cryopreservation in closed-system vials.

BioTek Instruments Receives 5x5x5 Growth Award for Technology
Wednesday, July 29, 2015
BioTek Instruments has been recognized as one of the 5x5x5 Growth Award winners for 2015.

New Weapon in the Fight Against Blood Cancer
Tuesday, July 28, 2015
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 2420
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos